chlordiazepoxide hydrochloride and clidinium bromide
Generic: chlordiazepoxide hydrochloride and clidinium bromide
Labeler: american health packagingDrug Facts
Product Profile
Brand Name
chlordiazepoxide hydrochloride and clidinium bromide
Generic Name
chlordiazepoxide hydrochloride and clidinium bromide
Labeler
american health packaging
Dosage Form
CAPSULE
Routes
Active Ingredients
chlordiazepoxide hydrochloride 5 mg/1, clidinium bromide 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
60687-639
Product ID
60687-639_2139df8d-62e0-c4f7-e063-6294a90a70c6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA214065
DEA Schedule
civ
Listing Expiration
2026-12-31
Marketing Start
2022-01-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
60687639
Hyphenated Format
60687-639
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Generic Name
chlordiazepoxide hydrochloride and clidinium bromide (source: ndc)
Application Number
ANDA214065 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 5 mg/1
- 2.5 mg/1
Packaging
- 20 BLISTER PACK in 1 CARTON (60687-639-94) / 1 CAPSULE in 1 BLISTER PACK (60687-639-11)
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "2139df8d-62e0-c4f7-e063-6294a90a70c6", "openfda": {"unii": ["MFM6K1XWDK", "91ZQW5JF1Z"], "rxcui": ["889614"], "spl_set_id": ["0fb80410-4689-4b8e-bfbb-19a62c9fe888"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "20 BLISTER PACK in 1 CARTON (60687-639-94) / 1 CAPSULE in 1 BLISTER PACK (60687-639-11)", "package_ndc": "60687-639-94", "marketing_start_date": "20220106"}], "brand_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "product_id": "60687-639_2139df8d-62e0-c4f7-e063-6294a90a70c6", "dosage_form": "CAPSULE", "pharm_class": ["Anticholinergic [EPC]", "Benzodiazepine [EPC]", "Benzodiazepines [CS]", "Cholinergic Antagonists [MoA]", "Decreased Parasympathetic Acetylcholine Activity [PE]", "Digestive/GI System Activity Alteration [PE]", "GI Motility Alteration [PE]"], "product_ndc": "60687-639", "dea_schedule": "CIV", "generic_name": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Chlordiazepoxide Hydrochloride and Clidinium Bromide", "active_ingredients": [{"name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "strength": "5 mg/1"}, {"name": "CLIDINIUM BROMIDE", "strength": "2.5 mg/1"}], "application_number": "ANDA214065", "marketing_category": "ANDA", "marketing_start_date": "20220106", "listing_expiration_date": "20261231"}